Beam Therapeutics BEAM
NASDAQ BEAM
$24.39 -0.06 (-0.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Long-Term Investments (2020 - 2021)

Updated

Beam Therapeutics (BEAM) reported Long-Term Investments of $24.54 million for Q3 2021, down 16.6% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Long-Term Investments (2020 - 2021) Analysis & Trends

At the end of FY2020, Beam Therapeutics posted Long-Term Investments of $2.58 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Beam Therapeutics 2.52 Bn 2.52 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 24.54 Mn
Jun 30, 2021 29.43 Mn
Dec 31, 2020 2.58 Mn
API Access

Beam Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BEAM&period=max&api_key=YOUR_API_KEY